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Abstract
Background: Phosphoinositide 3-kinase γ (PI3Kγ) has been depicted as a major regulator of inflammatory processes, 
including leukocyte activation and migration towards several chemokines. This study aims to explore the role of PI3Kγ 
in the murine model of antigen-induced arthritis (AIA).
Methods: Development of AIA was investigated in wildtype and PI3Kγ-deficient mice as well as in mice treated with a 
specific inhibitor of PI3Kγ (AS-605240) in comparison to untreated animals. Inflammatory reactions of leukocytes, 
including macrophage and T cell activation, and macrophage migration, were studied in vivo and in vitro.
Results: Genetic deletion or pharmacological inhibition of PI3Kγ induced a marked decrease of clinical symptoms in 
early AIA, together with a considerably diminished macrophage migration and activation (lower production of NO, IL-
1β, IL-6). Also, macrophage and neutrophil infiltration into the knee joint were impaired in vivo. However, T cell 
functions, measured by cytokine production (TNFα, IFNγ, IL-2, IL-4, IL-5, IL-17) in vitro and DTH reaction in vivo were not 
altered, and accordingly, disease developed normally at later timepoints
Conclusion: PI3Kγ specifically affects phagocyte function in the AIA model but has no impact on T cell activation.
Background
Rheumatoid arthritis (RA) is a painful and disabling auto-
immune disorder, affecting about one percent of the pop-
ulation in Western countries [1]. As a main indication the
disease comprises chronic inflammation of pheripheral
joints, resulting in progressive destruction of articular
cartilage and bone [2]. Inflamed tissue is characterized by
infiltration of leukocytes, pannus formation and occur-
rence of aggressive synovial fibroblasts [1]. Enhanced
expression of several cytokines or matrix metalloprotei-
nases by these cells promotes pathogenicity [reviewed in
[3,4]]. Moreover, various chemotactic factors are pro-
duced or activated in the joint tissue, recruiting even
more leukocytes and exacerbating inflammation [5].
Despite major advantages during the last decade, cur-
rently available therapeutic approaches for RA have only
partial clinical benefit and are associated with consider-
able side effects. Treatment strategies include anti-
inflammatory or immunosuppressive drugs and biologi-
cals, e.g. antibodies against TNF. Recently, prevention of
leukocyte infiltration in inflamed tissue by blocking
chemokines or chemokine receptors has also been
explored but with limited success [6], possibly due to
redundancy, enabling efficient leukocyte responses, even
when one particular factor is blocked. Therefore current
investigations are directed to the suppression of mutual
intracellular signaling pathways shared by multiple
chemokines. One prominent protein, integrating
chemokine signaling in leukocytes, is PI3Kγ, a G-protein-
coupled receptor (GPCR) isoform of phosphoinositide 3-
kinases [7]. This enzyme was shown to regulate chemot-
actic responses of neutrophils, macrophages and T cells
to several stimuli, including IL-8, C5a and SDF-1α [8].
Furthermore, PI3Kγ is involved in oxidative burst induc-
tion in phagocytes [9,10] and activation of T cells [11,12].
Thus, ablation of PI3Kγ could prevent both, leukocyte
infiltration into joints and autoimmune activation.
Indeed, Camps et al. showed a marked suppression of
joint inflammation and reduced tissue destruction by
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inhibition of PI3Kγ activity in the mouse model of colla-
gen-induced arthritis (CIA) [13]. Our data, presented
here, prove a role for PI3Kγ in the early phase of murine
antigen-induced arthritis (AIA), which is due to
decreased phagocyte infiltration into the joint and
reduced macrophage activation. However, PI3Kγ-/- mice
showed unaltered inflammation at later time points
together with normal T cell responses in this model.
Methods
Animals
PI3Kγ-deficient (PI3Kγ-/-) mice were described before
[8] and backcrossed to the C57BL/6 background for more
than 10 generations. Wildtype and PI3Kγ-/- littermates
were raised in the Animal Research Facility, Friedrich
Schiller University, Jena, Germany. They were kept under
standardized conditions with food and water ad libitum
in a 12 hour light/dark rhythm. All animal studies were
approved by the local commission for animal protection.
Antigen-induced arthritis and delayed-type 
hypersensitivity reaction
Wildtype control and PI3Kγ-/- mice, age 7-8 wk, were
immunized s.c. at 21 and 14 days before AIA induction
with 100 μg of methylated BSA (mBSA; Sigma, Deisen-
hofen, Germany), dissolved in 50 μl 0.9% NaCl and emul-
sified with an equal volume of CFA (Sigma),
supplemented with 2 mg/ml Mycobacterium tuberculosis
(Difco). Additionally to immunization with mBSA/CFA,
5 × 108 heat inactivated Bordetella pertussis germs (Chi-
ron-Behring, Liederbach, Germany) were administered
i.p. Arthritis was induced by intraarticular inoculation of
100 μg mBSA in 25 μl normal saline solution (0.9% NaCl)
in the right knee joint (day 0), leading to development of
severe acute synovitis associated with subsequent carti-
lage and bone erosion in the arthritic joints. At days 2, 7
or 21, animals were sacrified by cervical dislocation.
Knees were dissected for histology, spleen and lymph
node cells were isolated, and macrophages were prepared
by rinsing peritoneal cavitiy with ice-cold PBS (see
below). For treatment experiments, PI3Kγ inhibitor AS-
605240 (Enzo, Loerrach, Germany) was dissolved in 0.9%
NaCl and orally administered every 12 hours for 7 days
with 50 mg/kg of body weight in a total volume of 200 μl.
Delayed-type hypersensitivity (DTH) reaction in the ear
was induced by intradermal injection of 5 μg of mBSA in
10 μl 0.9% NaCl at day 7 of AIA.
Clinical assessment of AIA and DTH
Knee swelling was measured during the devolution of
AIA at definite time points using an Oditest caliper
(Kroeplin, Schlüchtern, Germany). DTH reaction was
estimated by increase of ear thickness 24 and 48 h after
challenge. For histopathological exploration, knee joints
were fixed in 4.5% formaldehyde, decalcified with EDTA,
embedded in paraffin and cut into 5-μm-sections. Serra-
tions were stained with haematoxylin and eosin and eval-
uated in a blinded manner according to a histological
scoring system ranging from 0 to 3 (0: no, 1: mild, 2: mod-
erate, 3: severe alterations). The amount of fibrin exuda-
tion, the relative number and density of granulocytes in
synovial membrane and joint space allowed grading of
the acute inflammatory reaction, the relative number and
density of infiltrating mononuclear leukocytes in the syn-
ovial membrane, the degree of synovial hyperplasia, the
extent of infiltration and fibrosis in the periarticular
structures allowed grading of chronic inflammation. The
extent of damage of the cartilage surface and bone struc-
tures was also evaluated on a scale of 0-3, where 0 = no
damage, 1 = mild destruction, 2 = moderate destruction,
and 3 = severe destruction of cartilage and bone (exten-
sive area of chondrocyte death and cartilage destruction,
deep invasive bone erosions).
Immunohistochemical examinations
C r y o s e c t i o n s  o f  k n e e  j o i n t s  w e r e  f i x e d  i n  a c e t o n e ,
blocked with 4% milk/Tris, and stained with 10 μg/ml pri-
mary rat mAbs directed against mouse Mac-1 (mac-
rophages and neutrophil granulocytes; Medac, Wedel,
Germany) or Gr-1 (neutrophil granulocytes; BD Biosci-
ences, Heidelberg, Germany) for 1 h at 22°C, followed by
incubation with biotinylated secondary goat anti-rat IgG
Abs (Dako, Glostrup, Denmark). Preparations were re-
fixed in 1% formalin, and developed with diaminobenzi-
dine (Sigma) in 0.03% H2O2 after blocking endogenous
peroxidase activity with 0.3% H2O2 in 0.1 M NaN3. Sec-
tions were counterstained with Mayer's hematoxylin.
Peritoneal macrophage activation
Macrophages were isolated at different time points after
arthritis induction by peritoneal lavage of three mice with
7 ml ice-cold phosphate buffered saline containing 5 IU/
ml heparin (Liquemin N 2000, Roche, Grenzach-Whylen,
Germany) [14]. Cells were cultured for 24 hours ex vivo in
RPMI1640 medium supplemented with 10% FCS without
further restimulation; supernatants were collected and
cytokines analyzed by ELISA (see T cell activation). Pri-
mary antibodies for IL-1β and IL-6 and biotin-labeled
secondary antibodies were purchased from BD Biosci-
ences. Nitric oxide production was measured by Griess
reagent as described previously [15].
Migration assay
For  in vitro chemotaxis, 106  macrophages/ml were
applied to the upper compartment of transwell chambers
(Corning, Wiesbaden, Germany; 5 μm pore size) and 600
μl of medium with or without C5a were added to the
lower compartment. After 20 h incubation, membranesGruen et al. BMC Musculoskeletal Disorders 2010, 11:63
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were excised, upper sides were wiped clean and cells on
the lower side stained with cristal violet and counted
microscopically. PI3Kγ inhibitor AS-605240 was applied
at a concentration of 20 μM.
Akt phosphorylation
One million macrophages were starved for 4 hours,
restimulated with C5a for 5 min, lysed in Laemmli buffer
and subjected to SDS-PAGE and immunoblotting. Anti-
bodies were purchased from Cell Signalling (Frankfurt,
Germany; Akt, phospho-Akt) and Sigma (β-actin). Sec-
ondary HRP-coupled anti-mouse and anti-rabbit anti-
bodies were from KPL (Gaithersburg, USA).
T cell activation
Single cell suspensions were prepared from draining
lymph nodes and spleen and cultured at 106/ml in RPMI
1640 medium containing 10% FCS, 2 mM sodium pyru-
vate, 10 mM HEPES, 15 μg/ml L-glutamine, 5 μg/ml
streptomycin, 5 U/ml penicillin (Invitrogen, San Diego,
USA), 5 × 10-5 M β-mercaptoethanol (Sigma) in a humid-
ified atmosphere at 37°C, 5% CO2 in the presence of 25
μg/well mBSA or 2 μg/well of plate-bound anti-CD3 anti-
bodies from 1452C11 hybridoma cell supernatant. Super-
natants were harvested after 42 h and analyzed for levels
of secreted cytokines using standard sandwich ELISA
procedures as previously described [16]. Primary and
biotin-labeled secondary Abs for IL-2, IL-4, IL-5, IL-17,
IFNγ, and TNFα were purchased from BD Biosciences.
Detection limit was 10 pg/ml for all ELISAs used.
Statistical analysis
Differences between the groups were evaluated using
nonparametric Mann-Whitney U-test and considered
statistically significant with p < 0.05. All calculations were
performed by means of the SPSS software package
(v.10.0.5). Outliers were identified using Grubbs-test.
Data are shown as arithmetic mean and SEM.
Results
Clinical symptoms of AIA are decreased in PI3Kγ-deficient 
mice
After arthritis induction, wildtype and knockout mice
developed rapid inflammation, indicated by acute joint
swelling. Knee diameter reached its maximum in both
strains at day 1 and declined afterwards. In PI3Kγ-/- mice
the swelling response at day 1 was markedly alleviated
compared to wildtype controls (figure 1A). This differ-
ence was evident for the next days and disappeared at
approximately day 7. Afterwards, joint diameter
decreased further, declining to baseline values at day 17
for both strains.
At days 2, 7, and 21, mice were sacrificed, histological
sections were taken and evaluated for arthritis score (fig-
ure 1B and table 1). Paralleling the joint swelling, signifi-
cant differences between wildtype and PI3Kγ-/- mice
were found at day 2, while disease scoring at later time-
points was essentially identical.
Reduced activation and migration of phagocytes
Maximal macrophage activation has been reported to
occur during the first days of AIA [17]. We speculated,
that amelioration of clinical symptoms during these days
might reflect impaired macrophage activity in the PI3Kγ-
/- mice. Peritoneal macrophages were isolated from ani-
mals at days 2 or 7 of AIA and tested ex vivo for produc-
tion of NO, IL-1β, and IL-6 without further restimulation.
None of these molecules could be detected in mac-
rophages of naïve mice (data not shown), while cells of
arthritic mice produced all three mediators. At all time-
points investigated, PI3Kγ-/- macrophages synthesized
significantly lower levels of NO, IL-1β, and IL-6 (figure
2A).
PI3Kγ is also known to control migration of phago-
cytes. Thus, we investigated peritoneal macrophages at
day 2 for their in vitro reaction to complement factor
C5a, a known chemotactic agent in AIA which signals via
PI3Kγ [8]. After starvation and restimulation with differ-
ent concentrations of C5a, phosphorylation of Akt
(pAkt), a major downstream target of PI3K, was investi-
gated. Wildtype macrophages showed pronounced phos-
phorylation in this experiment. In contrast, C5a was not
able to induce pAkt in PI3Kγ-deficient cells (figure 2B).
Moreover, in a transwell chemotaxis assay, wildtype cells
were much more responsive to C5a stimulation than
PI3Kγ-deficient macrophages. By adding the selective
PI3Kγ-inhibitor AS-605240 [13] to the assay, migration of
wildtype cells could be decreased nearly to the level,
observed with PI3Kγ-/- macrophages (figure 2C).
Finally, immunohistochemical analysis of inflamed
joints revealed a markedly reduced infiltration of PI3Kγ-
deficient macrophages and neutrophils to the inflamed
tissue in vivo (figure 2D). We conclude that loss of PI3Kγ
reduces activity and migration of innate immune cells at
early phases of AIA.
T cell reactions are largely unaltered in PI3Kγ-/- mice
Clinical markers of acute inflammation and markers of
macrophage activity passed through a maximum at day 2
(table 1 and figures 1 and 2). In contrast, chronic inflam-
matory reactions further increased later on. Moreover,
knee swelling and histological scoring were comparable
between wildtype and knockout animals at days 7 and 21
(figure 1 and table 1). This implicated pathogenic pro-
cesses independent of PI3Kγ. Since AIA depends on T
helper cells to a large extend [18], we tested the T cell
activation in the knockout mice. Splenocytes or cells
from draining lymph nodes were isolated at days 2, 7, andGruen et al. BMC Musculoskeletal Disorders 2010, 11:63
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Figure 1 Clinical manifestation of early AIA is decreased in PI3Kγ-/- mice. AIA was induced in C57BL/6 wildtype or PI3Kγ-/- littermates (n = 8) at 
day 0. (A) Joint swelling was measured during three weeks. Mean and SEM are shown, *: statistically significant difference, p < 0,05. (B) Mice were sac-
rificed at the indicated time points, histological sections were taken and evaluated microscopically (see table 1).
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21 and restimulated in vitro either polyclonally with anti-
CD3-antibodies or specifically with mBSA. Culture
supernatants were collected and TNFα, IFNγ, IL-2, IL-4,
and IL-5 were measured. There were no significant differ-
ences observed between either anti-CD3-stimulated
(data not shown) or mBSA-stimulated wildtype and
PI3Kγ-deficient cells (figure 3A). At day 2, IL-17 was
quantified additionally in the supernatants. Cells stimu-
lated with mBSA did not secrete detectable quantities of
this cytokine (data not shown), while after activation with
anti-CD3-antibodies comparable amounts of IL-17 were
produced by wildtype and PI3Kγ-deficient cells (table 2).
Cells of naïve mice did not secrete measurable amounts
of cytokines (data not shown).
To further investigate T cell immune reactions in vivo, a
delayed-type hypersensitivity test (DTH) was performed
at day 7 and ear swelling was measured 24 and 48 hours
later (figure 3B). No differences between the strains could
be detected, again pointing to normal T cell responses in
the PI3Kγ-/- mice.
Pharmacologic inhibition of PI3Kγ reduces joint swelling 
and macrophage activity in early AIA
Our data implicate specific functions of PI3Kγ in phago-
cytes during acute inflammatory responses. Neverthe-
less, the observed alleviation of clinical effects could also
be caused by a priming defect during the immunization
phase (days -21 to 0). To clarify this and mimick a thera-
peutic intervention, we again used the inhibitor AS-
605240. Wildtype C57BL/6 mice were immunized with
mBSA and randomly assigned to two groups at day 0.
One group was orally treated with AS-605240 (50 mg/kg
in PBS) twice a day for 7 days and the other group
received an equal volume of 0.9% saline. Joint swelling
and arthritis scores are shown in figure 4A and table 3.
The results reflected a similar situation as found with
PI3Kγ-/- animals. Joint swelling was markedly reduced in
treated mice during days 1 to 5 and was comparable to
controls afterwards. Arthritis scores were decreased at
day 2 in the group receiving AS-605240, although this
effect was not statistically significant. However, at day 7,
joint swelling and histological scoring were essentially
identical between both groups. In line with these clinical
parameters, peritoneal macrophage activity was
decreased by AS-605240 treatment at day 2 (figure 4B).
With an average reduction of about 20%, production of
NO, IL-1β, and IL-6, was not as strongly inhibited in this
experiment, as was observed with PI3Kγ-/- mice (com-
pare to figure 2A). Migration of wildtype macrophages
towards C5a could be inhibited by AS-605240 (see figure
2C). Cytokine production by T cells was not influenced
by the inhibitor at all (figure 4C). These results demon-
strate the potential of AS-605240, especially to alleviate
clinical signs of acute AIA (joint swelling) and, once
again, prove that chronic inflammatory processes in the
AIA model are independent of PI3Kγ.
Discussion
Our study aimed at elucidating the role of PI3Kγ in the
mouse model of AIA, which resembles many aspects of
RA in humans. PI3Kγ is known to control various effec-
tor functions of leukocytes, including migration (e.g.
extravasation from blood to tissue), oxidative burst,
cytokine production and phagocytosis [8-10,19,20]. This
suggests the kinase as a possbile exacerbating factor in
autoimmune disorders, including RA. Accordingly, in the
AIA model genetic or pharmacologic inactivation of
PI3Kγ results in considerably diminished manifestation
of early disease. Joint swelling two days after arthritis
induction was only about 60% of the controls and histo-
logical scoring in the knockouts revealed only about 40%
disease intensitiy compared to wildtype animals. These
findings are in line with studies on PI3Kγ in mouse mod-
els of CIA or serum-induced arthritis [13,21] and under-
line the importance of this molecule in acute
inflammatory processes. Quite surprisingly, in the AIA
model at later time points, PI3Kγ-/- mice revealed a fully
Table 1: Histological disease scoring of wildtype and PI3Kγ-/- mice during AIA (n = 8, mean ± SEM)
day 2 day 7 day 21
wt PI3Kγ-/- wt PI3Kγ-/- wt PI3Kγ-/-
acute 
inflammation
1,6 ± 0,5 0,7 ± 0,5 1,0 ± 0,4 0,8 ± 0,5 0,2 ± 0,2 0,2 ± 0,2
chronic 
inflammation
0,7 ± 0,3 0,1 ± 0,1 1,6 ± 0,5 1,4 ± 0,5 1,0 ± 0,4 0,8 ± 0,3
destruction 0,5 ± 0,2 0,3 ± 0,3 0,8 ± 0,1 0,7 ± 0,2 0,5 ± 0,2 0,4 ± 0,2
total score 2,8 ± 1,0 1,1 ± 0,9 3,4 ± 1,0 2,9 ± 1,2 1,7 ± 0,8 1,4 ± 0,7
bold: significant differences between groups (p < 0.05)Gruen et al. BMC Musculoskeletal Disorders 2010, 11:63
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Figure 2 Phagocyte functions are impaired in PI3Kγ-/- mice. Peritoneal macrophages of three wildtype and three knockout littermates were iso-
lated at different time points, cells were pooled and used for in vitro experiments. (A) Production of NO, IL-1β, and IL-6 was measured after 24 hours 
culture without restimulation. Mean and SEM of triplicates are shown for one of two experiments. < det: below detection limit (10 pg/ml) (B) Mac-
rophages isolated at day 2 of AIA were starved for 4 hours, restimulated for 5 min with C5a, as indicated, lysed and subjected to immunoblotting for 
Akt, phospho-Akt (pAkt), and β-actin. (C) Macrophages isolated at day 2 of AIA were seeded into transwell plates and migrated towards different con-
centrations of C5a for 20 hours. Afterwards, membranes were washed and cells at the lower side were stained and counted microscopically. One of 
two experiments is shown (mean and SEM). (D) Joint sections at day 2 of AIA were prepared and stained with Mac-1 (macrophages, neutrophils) or 
Gr-1 (neutrophils) specific antibodies (upper panel) and positive cells were counted (lower panel, mean and SEM of 6 animals). *: statistically significant 
difference, p < 0.05.
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Figure 3 T cell responses are normal in PI3Kγ-/- mice. (A) Splenocytes or cells of draining lymph nodes were isolated and restimulated in vitro with 
mBSA for 24 hours. Supernatants were collected and cytokine production was measured by ELISA (n = 6, one of two experiments shown). 1Two out-
liers were eliminated for day 7 (Grubbs test). (B) DTH reaction was induced at day 7 and ear swelling was determined 24 and 48 hours later.
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developed disease with knee swelling and histological
scoring being comparable between controls and knock-
outs. These observations were in contrast to both other
studies on PI3Kγ in arthritis [13,21] but may be explained
by different requirements for T cells among the three
models. Randis et al. [21] induced arthritis by serum
t r a n s f e r  f r o m  K / B x N  m i c e  t o  P I 3 K γ - / -  o n  a  C 5 7 B L / 6
background, a model that was reported to be indepen-
dent of lymphocytes [22]. Likewise, T cells are dispens-
able for the development of anti-CII antibody-induced
arthritis [23], one of the models investigated by Camps et
al. [13]. However, the same group also studied CIA,
which requires T cell activation, and found considerably
decreased disease symptoms upon treatment of mice
with AS-605240. The reason for this discrepancy is not
completely clear, but most probably, the relative contribu-
tion of innate immunity to CIA is much stronger than in
the later (chronic) phases of the AIA model. This might
be reflected by the different pattern of paw and knee
swelling: while paw thickness in the CIA model steadily
increases during the whole observation period, the knee
swelling in AIA has a maximum at day 1 and decreases
thereafter.
Macrophage activation peaked at day 2 in our experi-
ments, while main T cell responses were observed at days
7 and 21. From this, we hypothesized, that loss of PI3Kγ
mostly inhibits phagocyte activation and function,
whereas T cells are less or even not affected. Our data in
vivo and in vitro support this hypothesis: Effector pro-
duction by peritoneal macrophages (NO, IL-1β, IL-6) ex
vivo was clearly decreased in PI3Kγ-/- mice during the
course of AIA. It is important to note, that cytokine pro-
duction in this experiment was not induced by external
stimuli, specifically targeting GPCR receptors and PI3Kγ,
but rather reflected the state of in vivo macrophage prim-
ing. Thus, our results extend data of several groups,
investigating PI3Kγ-dependent activation of mac-
rophages  in vitro [9,10,20]. In our experiments, C5a
induced phosphorylation of Akt in wildtype macrophages
in vitro, while no phosphorylation could be observed in
PI3Kγ-/- cells. This is in line with previous reports [8,13]
and contradicts to some extend a recent study, showing
concerted and partially redundant action of PI3Kγ and
PI3Kβ isoforms downstream of GPCR [24]. These issues
require further investigation and clarification. Addition-
ally, macrophage migration towards C5a in vitro and infil-
tration of both, neutrophils and macrophages to the
inflamed joint in vivo were diminished in the PI3Kγ-/-
mice and migration of wildtype macrophages could be
blocked  in vitro by using AS-605240. Taken together,
innate immunity seems to be largely impaired by loss of
PI3Kγ, causing the marked alleviation of clinical symp-
toms at early days of AIA.
On the other hand, our experiments revealed no
changes in T cell activation of PI3Kγ-/- mice. Neither
cytokine production in vitro (TNFα, IFNγ, IL-2, IL-4, IL-
5, IL-17) was significantly altered, nor was the DTH reac-
tion  in vivo. Those results were somewhat surprising,
considering several reports on involvement of PI3Kγ in T
cell maturation, migration and activation [25-28]. How-
ever, most of those results were obtained in vitro, while in
vivo data are less clear. Most groups investigated an acute
activation of T cells by anti-CD3-antibodies in vitro or
migration of naïve T cells towards SDF-1α in a time frame
of several hours. Contrary, the immunization period of
the AIA model (3 weeks) might provide sufficient time
for efficient T cell priming and mounting of effector func-
tion. Moreover, in two models of systemic lupus erythe-
matosus, PI3Kγ was shown to control the CD4+ memory
T cell reservoir mostly in the context of a second genetic
alteration (MRL-lpr or p65PI3KTg), while single-targeted
PI3Kγ-inhibition revealed only modest phenotypes
[27,29]. Additionally, although defective T cell differenti-
ation can be detected in newborn PI3Kγ-deficient mice,
differences decrease in mice of about one month of age
[12]. Those data suggest an at least partial compensation
of PI3Kγ in vivo, dependend on the microenvironment
and activation status of the T cell. This premise is sup-
ported by recent studies of Ward and colleagues on
human T lymphocytes. The activation status or even cul-
ture conditions strongly influenced requirement of PI3Kγ
for migration in these experiments [30,31].
The DTH reaction at 24 and 48 hours post challenge
was unchanged in PI3Kγ-/- mice (days 8 and 9 of AIA).
This again demonstrates a largely unaltered T cell
response and suggests a compensation of deficient signal-
ing reactions in PI3Kγ-/- T cells by other proteins.
Although defective development of thymocytes or CD4
memory T cells as described by Rodriguez-Borlado et al.
[12] and Barber et al. [27] was not addressed by our
Table 2: IL-17 content in supernatants of anti-CD3-stimulated cell cultures (n = 5, mean ± SEM)
IL-17 (pg/ml)
wt PI3Kγ-/-
spleen 68 ± 54 67 ± 49
lymph nodes 443 ± 61 318 ± 69Gruen et al. BMC Musculoskeletal Disorders 2010, 11:63
http://www.biomedcentral.com/1471-2474/11/63
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Figure 4 Pharmacologic inhibition of PI3Kγ alleviates joint swelling and macrophage activity. Wildtype C57BL/6 mice were immunized with 
mBSA, AIA was induced and animals randomly assinged to two groups, receiving either AS-605240 or vehicle (saline) for 7 consecutive days. (A) Knee 
swelling was measured as a clinical marker of AIA. n = 5, *: p < 0.05, ** p < 0.01 (B) Peritoneal macrophages were isolated at day 2 of AIA, cultured for 
24 hours without restimulation and production of effector molecules was measured in the culture supernatant (mean and SEM of triplicates). (C) Sple-
nocytes and lymph node cells were isolated at day 2 and 7 of AIA, cultured for 24 hours in the presence of mBSA and cytokines were measured in the 
supernatants.
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experiments, this does not seem to primarily influence
disease development.
The effects of genetic ablation of PI3Kγ could be mim-
icked largely by using the inhibitor AS-605240, specific
for PI3Kγ. This compound was able to markedly decrease
macrophage activation and joint swelling during the first
days (acute phase) of AIA, in accordance to Camps et al.
[13]. Efficacy of AS-605240 in both models points to a
possible impact in human rheumatoid arthritis too and
asks for further development of this drug candidate
towards clinical use. Although T cell activation was not
influenced by the inhibitor, its ability to alleviate clinical
parameters specifically during early AIA suggests a
potential of AS-605240 or other PI3Kγ inhibitors prefer-
entially in therapy of acute exacerbations of the disease, a
hallmark of chronic RA in humans.
Conclusions
In summary, PI3Kγ has its greatest impact on AIA during
the first days of the inflammation, when innate immune
cells dominate pathogenesis. The enzyme controls pro-
duction of NO and cytokines by macrophages and migra-
tion of macrophages and neutrophils. Deletion or
inhibition of PI3Kγ does not influence T cell responses in
the AIA model. Accordingly, disease becomes fully devel-
oped at later stages, as judged from T cell cytokine pro-
duction and histological sections of inflamed joints.
Thus, influence of PI3Kγ on adaptive immune reactions
is rather limited in this model.
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